Literature DB >> 8248534

Subtype selective muscarinic agonists: potential therapeutic agents for Alzheimer's disease.

R Davis1, C Raby, M J Callahan, W Lipinski, R Schwarz, D T Dudley, D Lauffer, P Reece, J Jaen, H Tecle.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8248534     DOI: 10.1016/s0079-6123(08)62430-9

Source DB:  PubMed          Journal:  Prog Brain Res        ISSN: 0079-6123            Impact factor:   2.453


× No keyword cloud information.
  2 in total

1.  Scientific and ethical concerns in clinical trials in Alzheimer's patients: the bridging study.

Authors:  N R Cutler; J J Sramek
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

Review 2.  Potential role of muscarinic agonists in Alzheimer's disease.

Authors:  E E Avery; L D Baker; S Asthana
Journal:  Drugs Aging       Date:  1997-12       Impact factor: 3.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.